Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
Submitted by
admin
on October 16, 2017 - 9:37pm
Source:
GoinPharma
News Tags:
Alzheimer's disease
Ionis Pharmaceuticals
IONIS-MAPTRx
antisense
Headline:
Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
Do Not Allow Advertisers to Use My Personal information
